Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CANCER IMMUNOTHERAPY

How to kill Treg cells for immunotherapy

Achieving depletion of regulatory T cells while sparing tumor-specific effector T cells has long remained an elusive goal of immunotherapy. A new study describing the development of an antibody to the cytokine receptor CD25 optimized to ensure depletion of regulatory T cells without blocking binding of the cytokine IL-2 will reinvigorate interest in this therapeutic avenue.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Anti-CD25NIB depletes organisms of Treg cells to enhance tumor killing.

References

  1. 1.

    Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. J. Immunol. 155, 1151–1164 (1995).

    CAS  PubMed  Google Scholar 

  2. 2.

    Onizuka, S. et al. Cancer Res. 59, 3128–3133 (1999).

    CAS  PubMed  Google Scholar 

  3. 3.

    Woo, E. Y. et al. J. Immunol. 168, 4272–4276 (2002).

    CAS  Article  Google Scholar 

  4. 4.

    Shang, B., Liu, Y., Jiang, S. J. & Liu, Y. Sci. Rep. 5, 15179 (2015).

    CAS  Article  Google Scholar 

  5. 5.

    Solomon, I. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-00133-0 (2020).

  6. 6.

    Jacobs, J. F. et al. Clin. Cancer Res. 16, 5067–5078 (2010).

    CAS  Article  Google Scholar 

  7. 7.

    Rech, A. J. et al. Sci. Transl. Med. 4, 134ra162 (2012).

    Article  Google Scholar 

  8. 8.

    Thornton, A. M. & Shevach, E. M. J. Exp. Med. 188, 287–296 (1998).

    CAS  Article  Google Scholar 

  9. 9.

    Arce Vargas, F. et al. Immunity 46, 577–586 (2017).

    CAS  Article  Google Scholar 

  10. 10.

    van Elsas, A., Hurwitz, A. A. & Allison, J. P. J. Exp. Med. 190, 355–366 (1999).

    Article  Google Scholar 

  11. 11.

    Suntharalingam, G. et al. N. Engl. J. Med. 355, 1018–1028 (2006).

    CAS  Article  Google Scholar 

  12. 12.

    Loskog, A. et al. Leukemia 20, 1819–1828 (2006).

    CAS  Article  Google Scholar 

  13. 13.

    Rafiq, S. et al. Nat. Biotechnol. 36, 847–856 (2018).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to James L. Riley.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ellis, G.I., Riley, J.L. How to kill Treg cells for immunotherapy. Nat Cancer 1, 1134–1135 (2020). https://doi.org/10.1038/s43018-020-00155-8

Download citation

Search

Quick links